HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cardiac transplantation in the rat. I. The effect of histocompatibility differences on graft arteriosclerosis.

Abstract
The development of arteriosclerosis is the most serious and common complication in long-term survivors of cardiac transplantation. We have used a variety of inbred rat strains with selected histocompatibility differences to examine the influence of prolonged, mild rejection reactions on the development of pathological changes in long-term cardiac allografts. Heterotopic cardiac allografts were exchanged between rat strains that differed for MHC class I (RT1.A and/or RT1.E) antigens or groups of minor, non-MHC antigens in MHC-compatible congenic combinations. Our results demonstrate that in strain combinations in which the allograft reaction is mild and prolonged, the donor hearts exhibit pathological changes that include a diffuse, interstitial myocardial fibrosis, perivascular fibrosis, and intimal proliferation in arteries of the graft myocardium. The lesions were less prominent in animals with more active rejection and infrequent in strains that differ for class I histocompatibility antigens or syngeneic controls. These results suggest that the comparable pathological changes seen in long-term human cardiac survivors may reflect low-level, persistent allograft reactions rather than factors associated with graft anoxia or effects of immunotherapy to prevent graft rejection.
AuthorsD V Cramer, S Q Qian, J Harnaha, F A Chapman, L W Estes, T E Starzl, L Makowka
JournalTransplantation (Transplantation) Vol. 47 Issue 3 Pg. 414-9 (Mar 1989) ISSN: 0041-1337 [Print] United States
PMID2646772 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Topics
  • Animals
  • Arteriosclerosis (etiology)
  • Coronary Vessels (pathology)
  • Graft Survival
  • Heart Transplantation
  • Major Histocompatibility Complex
  • Rats
  • Rats, Inbred BN
  • Rats, Inbred Strains
  • Transplantation, Heterologous (adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: